GLOBAVIR
Globavir was founded in 2011 by Dr. Shalabh Gupta. Globavir was built on multiple licenses from Stanford University from multiple different professors and multiple different departments. In 2014, Globavir acquired BioCycive in all stock deal, and BioCycive became a wholly owned subsidiary of Globavir. In 2015, BioCycive's lead program was partnered with Sorrento Therapeutics. In 2016, Globavir partnered its diagnostic test with Bio-Rad.
GLOBAVIR
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2013-07-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.globavir.com
Total Employee:
11+
Status:
Active
Contact:
+116503514495
Total Funding:
11.5 M USD
Technology used in webpage:
SPF LetsEncrypt Apache Euro Google Apps For Business Unified Layer BlueHost BlueHost DNS
Current Advisors List
Board_member
Advisor
2015-04-01
Advisor
2013-01-01
Board_member
2011-01-01
Current Employees Featured
Shalabh Gupta Founder, President & CEO @ Globavir
Founder, President & CEO
2011-01-01
Vijay Pande Co-Founder @ Globavir
Co-Founder
2014-01-01
Founder
Investors List
StartX (Stanford-StartX Fund)
StartX (Stanford-StartX Fund) investment in Venture Round - Globavir
Sorrento Therapeutics
Sorrento Therapeutics investment in Venture Round - Globavir
Official Site Inspections
http://www.globavir.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
Unable to get host informations!!!
More informations about "Globavir"
Globavir Biosciences 2025 Company Profile: Valuation, …
Globavir Biosciences General Information Description. Operator of a biopharmaceutical company intended for the treatment of global infectious …See details»
Globavir Biosciences - Products, Competitors, Financials, …
Globavir is a specialty biotechnology company with a unique approach to unlocking the potential of the 505(b)(2) regulatory path. Globavir leverages its highly predictive, machine learning …See details»
Globavir - VentureRadar
Globavir's development strategy harnesses the advantages offered by the 505(b)2 regulatory pathway, allowing for rapid development of new therapies. Globavir is initially focused on the …See details»
Globavir Biosciences, Inc. Company Profile | Los Altos, CA ...
Find company research, competitor information, contact details & financial data for Globavir Biosciences, Inc. of Los Altos, CA. Get the latest business insights from Dun & Bradstreet.See details»
Globavir Biosciences - Overview, News & Similar companies
Dec 18, 2017 Who is Globavir Biosciences. Globavir Biosciences, based in Los Altos, CA, is developing life-saving technologies for cancer and the diagnosis and treatment of some of the …See details»
Globavir Biosciences, Inc. Overview | SignalHire Company Profile
Globavir Biosciences, Inc. is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology area. The position of the Founder & CEO …See details»
Globavir - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Globavir Biosciences Inc. in Los Altos, California - EIN TaxId
The Employer Identification Number (EIN) for Globavir Biosciences Inc. is 46-3096282. EIN numbers are also referred to as FEIN or FTIN. Find EIN, Contact Details for Globavir …See details»
Globavir Biosciences, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Globavir Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:GBV-006, GBV-015, GBV-012, GBV-1012, GBV-3019. ... The statistics for drugs …See details»
Globavir Biosciences - Craft
Globavir Biosciences is a biotechnology company that develops therapeutics for infectious diseases and oncology, and diagnostics for infectious diseases. Globavir's platform discovery …See details»
Globavir Biosciences - Golden
Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was …See details»
Globavir, Inc. - Los Altos, USA - bionity.com
Globavir's Infectious Disease pipeline includes GBV006, a broad spectrum antiviral being evaluated for the treatment of Chikungunya and Dengue infections Globavir also offers best-in …See details»
Globavir Biosciences Inc - Company Profile and News
Globavir Biosciences, Inc. is an infectious disease-focused company. Globavir researches and develops therapeutics to address certain infectious diseases such as Dengue, West Nile, …See details»
Globavir Biosciences - Company info. interviews, news
Aug 18, 2022 Globavir Biosciences is a San Francisco Bay Area based company committed to the development of therapeutics and diagnostics for the treatment of global infectious …See details»
Globavir - Team members, CEO, Employees
Globavir is focused on commercializing re-purposed drugs for controlling diseases with large unmet medical needs such as Coronavirus, Dengue Fever, Ebola, and Chikungunya. …See details»
Globavir - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Globavir . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Globavir | CipherBio
Explore Globavir's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
NeOnc Technologies Expands Global Clinical Trial Network with …
15 hours ago WESTLAKE VILLAGE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq Global Market: NTHI), a clinical-stage medical …See details»
U.S. could lose democracy status, says global watchdog
Mar 18, 2025 Possibly defying a court order. Urging his Justice Department to prosecute nemeses. Repeatedly calling the media 'illegal.' Declaring a predecessor's pardon null and …See details»
WHO calls for urgent action to address worldwide disruptions in ...
Mar 20, 2025 On the occasion on World Tuberculosis (TB) Day, marked on 24 March, the World Health Organization (WHO) is calling for an urgent investment of resources to protect and …See details»